Leiv Lea, Chief Financial Officer at Corvus Pharmaceuticals, Inc. (CRVS), bought 84,198 shares at $1.54 ($131K) on 2022-03-16, disclosed to the SEC on 2022-03-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.54 | 35,160 | $54K | 41.3% |
| 2 | $1.54 | 35,160 | $54K | 41.3% |
| 3 | $1.65 | 13,878 | $23K | 17.5% |
| Total | $1.56 avg | 84,198 | $131K | 100% |
| Filing → |
| CRVS | BUY | 2018-12-27 | $205K | — | Filing → |
| PCYC | BUY | 2007-08-22 | $4K | — | Filing → |
| PCYC | BUY | 2007-08-22 | $6K | — | Filing → |